Citadel Advisors
CVRX icon

Citadel Advisors’s CVRx CVRX Stock Holding History

Citadel Advisors’s Portfolio CVRX Stock Details CVRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$177K Buy
+18,700
New +$137K ﹤0.01% 11535
2025
Q4 		– Sell
-45,300
Closed -$366K – 12853
2025
Q3 		$366K Buy
45,300
+3,100
+7% +$23.3K ﹤0.01% 9882
2025
Q2 		$248K Sell
42,200
-1,200
-3% -$8.28K ﹤0.01% 10230
2025
Q1 		$531K Sell
43,400
-22,400
-34% -$316K ﹤0.01% 8346
2024
Q4 		$834K Buy
65,800
+9,500
+17% +$117K ﹤0.01% 7430
2024
Q3 		$496K Buy
56,300
+47,300
+526% +$430K ﹤0.01% 8269
2024
Q2 		$108K Sell
9,000
-6,300
-41% -$72.5K ﹤0.01% 10813
2024
Q1 		$279K Sell
15,300
-9,100
-37% -$216K ﹤0.01% 9610
2023
Q4 		$767K Sell
24,400
-18,200
-43% -$341K ﹤0.01% 7217
2023
Q3 		$646K Buy
42,600
+4,700
+12% +$77.3K ﹤0.01% 7505
2023
Q2 		$585K Sell
37,900
-45,800
-55% -$559K ﹤0.01% 7592
2023
Q1 		$780K Buy
83,700
+67,900
+430% +$898K ﹤0.01% 7332
2022
Q4 		$290K Buy
+15,800
New +$195K ﹤0.01% 9386

Other funds holding CVRX

JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GP
GSK plc London $599M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors's CVRX Position: Q1 2026 in Review

Citadel Advisors reduced its CVRx (CVRX) stake by 91% in Q1 2026, selling an estimated $2.04M and leaving 26,627 shares worth $252K. The position accounts for ﹤0.01% of the portfolio, ranked #10894.

Citadel Advisors first reported a position in CVRX in Q2 2021 and has held it in 14 quarters since. The position peaked at $3.12M in Q1 2025. 99 funds tracked by Wall St. Rank hold CVRX as of Q1 2026.

  • Citadel Advisors held 26,627 shares of CVRx worth $252K as of Q1 2026.
  • Citadel Advisors sold 278,876 CVRx shares in Q1 2026, an estimated $2.04M.
  • CVRx made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #10894 holding.
  • Citadel Advisors first reported a position in CVRx in Q2 2021 and has held it in 14 quarters since.
  • Citadel Advisors's CVRx position peaked at $3.12M in Q1 2025.
  • 99 funds tracked by Wall St. Rank held CVRx as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.